PhaseBio Pharmaceuticals Overview

PhaseBio Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for PHAS.

Quarterly Other Income/Expense

-$116000.00

↑ 98.08% YoY

As of Jun 30, 2022

Annual Other Income/Expense (TTM)

-$2.85M

↑ 83.02% YoY

Trailing 12 months ending Jun 30, 2022

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin